FT商学院

Nobel laureate Al Roth and the economics of organ sales

Economists gonna economist

The economist Alvin Roth been talking about kidneys since at least 2003, noting time and again that kidneys are in short supply, waiting lists are growing longer, and people are dying as a result.

So why is Roth — who appears on this week’s episode of the Economics Show podcast — still banging on about kidneys? Well, because all of those things are still getting worse.

Take the US. The number of kidney transplants carried out each year has been growing, which is good news.

您已阅读19%(475字),剩余81%(1971字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×